In mice with sepsis-induced acute kidney injury, SS‑31 lowered serum creatinine compared with the sepsis model group.
In plain wordsIn mice with sepsis kidney injury, SS‑31 lowered serum creatinine compared with untreated sepsis mice.
- Peptide
- Elamipretide (SS-31)
- Outcome
- DecreaseSerum creatinine
- Study
mousen: not reported in source
Cecal ligation and puncture sepsis-induced acute kidney injury- Comparator
- Sepsis model group (saline)
- Outcome group
- Kidney function · Kidney and urinary
- Studied dose
- 5 mg/kg · intraperitonealAs given in this study (mouse).
Measurements
- SCr
- 71.33 μmol/L
- SS-31 group
- SCr
- 93.12 μmol/L
- sepsis model group
Source sentences
compared with sepsis model group, the levels of SCr, BUN and the expressions of AMPK, PGC-1α, cleaved caspase-3 protein were significantly decreased in the SS-31 peptide group
3 context sentences(design, population, supporting numbers)
[SCr (μmol/L): 71.33±10.14 vs. 93.12±11.80, BUN (mmol/L): 27.00±5.52 vs. 41.36±6.48, AMPK/β-actin: 0.23±0.01 vs. 0.30±0.02, PGC-1α/β-actin: 0.27±0.02 vs. 0.38±0.03, cleaved caspase-3/β-actin: 0.13±0.01 vs. 0.20±0.01, all P < 0.05].
The sepsis-induced AKI mouse model was reproduced by cecal ligation and puncture (CLP).
SS-31 peptide (5 mg/kg) was intraperitoneally injected in SS-31 peptide group and positive control group 30 minutes after the operation, while an equivalent amount of normal saline was given in sham group and sepsis model group for 7 days.